This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

J&J Recalls, Stops Selling 3 Versions Of K-Y Jelly

By LINDA A. JOHNSON

Johnson & Johnson has quietly recalled some of its popular personal lubricants in order to avert potentially expensive new regulatory reviews.

In the latest in a string of J&J recalls, the health products giant's McNeil unit removed three types of K-Y Jelly from pharmacy and grocery store shelves, and recalled packages from wholesalers, at the end of January. The recalled brands are K-Y Tingling Jelly, K-Y Sensitive Jelly and K-Y Silk-E Vaginal Moisturizer and Personal Lubricant.

McNeil said Friday that all three are safe and there are no "product performance issues," so consumers can keep using any they have left.

But McNeil doesn't plan to return them to the market after the company determined that each might require a detailed review by regulators. McNeil had considered them similar enough to existing products to not require such a review.

That's because the lubricants are considered medical devices, rather than medicines. Devices that are equivalent to one already on the market can be sold without a detailed review by the U.S. Food and Drug Administration.

"As part of ongoing and detailed internal reviews we decided that these products may require submission of new data and application for a new medical device" approval, McNeil spokeswoman Samantha Lucas wrote in an email response to questions. "Because we decided against submitting new paperwork, we recalled the small amount of product that was still in the market."

"This was a business-driven decision," she added.

About a dozen types of K-Y Jelly are still available. One other version previously was recalled, but McNeil is working on bringing that one back.

Last July, J&J took its K-Y Liquibeads vaginal lubricant off the market, recalling about 69,000 packages of the product. The company said then that the FDA had decided Liquibeads, which the agency had approved as an extension of K-Y Intrigue lubricant, actually needed to go through the full approval process.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,061.69 +23.72 0.13%
S&P 500 2,109.69 +0.77 0.04%
NASDAQ 5,059.9660 -0.28 -0.01%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs